Choosing a research peptide supplier is one of the most consequential decisions a lab makes. Quality varies more than people expect, and a bad batch can quietly ruin months of work. This article walks through what experienced researchers actually check before placing an order.
Testing and Purity Documentation
The first thing to check is whether the supplier provides a Certificate of Analysis (COA) for the specific batch. A real COA shows the assay method (typically HPLC), the measured purity percentage, and the date the test ran.
Purity below 95% is generally considered unsuitable for serious research. Better suppliers report 98% or higher and back the figure with mass spectrometry confirming the molecular weight matches the expected sequence.
Researchers should be wary of generic COAs that look identical from batch to batch. A real testing process produces small variations in trailing peaks and impurity profiles. If every COA looks identical, something is off.
Transparency About Sourcing
Some peptides are synthesized in-house; many are sourced from contract manufacturers. Either is acceptable, but the supplier should be able to say which manufacturers they use and what quality standards apply.
Cold-chain handling matters too. Peptides stored or shipped at improper temperatures can degrade silently — the powder still looks fine, but activity drops. Suppliers who explain their temperature controls and shipping practices are usually more careful overall.
It's also worth asking how long peptides sit in inventory before shipping. Most lyophilized peptides are stable at minus 20 Celsius for years, but warm warehouse storage shortens that window dramatically.
Compliance and Labeling
Legitimate research peptide suppliers in the United States label products as "Research Use Only" and decline to make claims about human use. They also avoid product names that imply medical purpose.
Researchers should expect a clear scope statement from the supplier explaining who they sell to and under what terms. Suppliers that aggressively market to consumers, mention specific dosing protocols, or imply therapeutic effects are operating outside the research-use framework — and any data generated with their products may face scrutiny later.
Documentation that survives an audit matters. Keep COAs, packing slips, and storage logs in the same folder as the experimental data.
Responsiveness and Pricing
Quality suppliers answer technical questions. Ask about purification methods, residual solvent testing, or endotoxin levels — a real supplier will know the answers or find out quickly. Long delays or vague replies are a warning sign.
Pricing is another signal. Peptide synthesis has real costs, and a price that seems dramatically lower than competitors usually reflects either lower purity, gray-market sourcing, or short shelf life. The cheapest option rarely turns out to be the cheapest after you account for failed experiments.
The peptide research field is still standardizing what supplier evaluation should look like, and best practices are evolving. Researchers should verify each supplier's documentation independently and treat any peptide they purchase as research use only — not for human consumption.